MeSH term
Frequency | Condition_Probility | Binding Sites/genetics | 7 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Humans | 180 | 0.0 |
Phenotype | 4 | 0.0 |
*Proto-Oncogene Proteins | 8 | 0.0 |
Research Support, Non-U.S. Gov't | 126 | 0.0 |
5' Untranslated Regions | 2 | 1.0 |
Animals | 87 | 0.0 |
Base Sequence | 58 | 0.0 |
Binding Sites | 27 | 0.0 |
COS Cells | 4 | 0.0 |
Cell Line | 40 | 0.0 |
*Gene Expression Regulation | 8 | 0.0 |
Hela Cells | 18 | 0.0 |
Luciferases/metabolism | 7 | 1.0 |
Mice | 41 | 0.0 |
Models, Genetic | 3 | 0.0 |
Molecular Sequence Data | 51 | 0.0 |
Mutagenesis, Site-Directed | 8 | 0.0 |
Mutation | 13 | 0.0 |
Phosphorylation | 20 | 0.0 |
*Protein Biosynthesis | 2 | 0.0 |
Protein Isoforms | 3 | 0.0 |
RNA, Messenger/metabolism | 11 | 0.0 |
Rats | 27 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Transfection | 39 | 0.0 |
Tumor Cells, Cultured | 50 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Blotting, Western | 19 | 0.0 |
Caspases/metabolism | 2 | 0.0 |
Cell Death | 2 | 0.0 |
Culture Media, Serum-Free/pharmacology | 2 | 1.0 |
Enzyme Activation | 7 | 0.0 |
Enzyme Inhibitors/pharmacology | 10 | 0.0 |
MAP Kinase Signaling System | 2 | 0.0 |
Mitogen-Activated Protein Kinase 1/metabolism | 3 | 0.0 |
Mitogen-Activated Protein Kinase 8 | 3 | 3.0 |
Mitogen-Activated Protein Kinases/metabolism | 11 | 1.0 |
Precipitin Tests | 5 | 0.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-jun/*metabolism | 14 | 18.0 |
Research Support, U.S. Gov't, P.H.S. | 74 | 0.0 |
Signal Transduction | 9 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 19 | 1.0 |
Time Factors | 13 | 0.0 |
*Ultraviolet Rays | 2 | 0.0 |
p38 Mitogen-Activated Protein Kinases | 7 | 1.0 |
DNA-Binding Proteins/*metabolism | 13 | 0.0 |
Gene Expression Regulation, Neoplastic | 5 | 0.0 |
NF-kappa B/*metabolism | 7 | 1.0 |
Proto-Oncogene Proteins c-fos/genetics | 5 | 9.0 |
Proto-Oncogene Proteins c-jun/genetics | 6 | 15.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Trans-Activators/*metabolism | 6 | 0.0 |
Transcription Factor AP-1/*metabolism | 34 | 21.0 |
Aged | 6 | 0.0 |
DNA/*metabolism | 4 | 0.0 |
Female | 21 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Cells, Cultured | 30 | 0.0 |
Chromatography, Affinity | 2 | 0.0 |
DNA/metabolism | 10 | 0.0 |
DNA-Binding Proteins/metabolism | 17 | 0.0 |
Electrophoretic Mobility Shift Assay | 3 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Oxidation-Reduction | 3 | 0.0 |
Protein Structure, Tertiary | 6 | 0.0 |
Trans-Activators/metabolism | 7 | 0.0 |
Cell Line, Transformed | 7 | 0.0 |
Trans-Activation (Genetics)/physiology | 5 | 5.0 |
Antioxidants/metabolism | 2 | 2.0 |
Transcription Factors/metabolism | 14 | 0.0 |
ras Proteins/metabolism | 4 | 2.0 |
Amino Acid Motifs | 2 | 0.0 |
Cell Nucleus/metabolism | 11 | 0.0 |
Cytoplasm/metabolism | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 4 | 0.0 |
Genes, Reporter | 13 | 0.0 |
Immunoblotting | 6 | 0.0 |
Promoter Regions (Genetics) | 22 | 0.0 |
Protein Binding | 31 | 0.0 |
Proto-Oncogene Proteins c-jun/metabolism | 18 | 13.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Transcription, Genetic | 25 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Cell Division | 9 | 0.0 |
Models, Biological | 8 | 0.0 |
Cell Separation | 2 | 0.0 |
Gene Expression Regulation | 14 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Signal Transduction/physiology | 7 | 0.0 |
3T3 Cells | 7 | 0.0 |
Enhancer Elements (Genetics) | 6 | 1.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Transcription Factor AP-1/genetics | 2 | 7.0 |
Transforming Growth Factor beta/*pharmacology | 4 | 1.0 |
Comparative Study | 10 | 0.0 |
Proto-Oncogene Proteins c-fos/*metabolism | 5 | 14.0 |
Transcription Factors/*metabolism | 10 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 9 | 1.0 |
MAP Kinase Kinase 1 | 2 | 1.0 |
*MAP Kinase Signaling System | 3 | 2.0 |
Mitogen-Activated Protein Kinase 3 | 4 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 3 | 1.0 |
Protein-Serine-Threonine Kinases/metabolism | 4 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 3 | 0.0 |
U937 Cells | 2 | 0.0 |
Carcinogens/pharmacology | 2 | 2.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Promoter Regions (Genetics)/physiology | 3 | 1.0 |
Proto-Oncogene Proteins c-raf/metabolism | 3 | 3.0 |
Gene Expression Regulation/*physiology | 4 | 1.0 |
*MAP Kinase Kinase Kinase 1 | 3 | 2.0 |
Protein Precursors/*genetics | 2 | 1.0 |
Transcription Factor AP-1/*physiology | 5 | 14.0 |
Lymphocyte Activation | 2 | 0.0 |
*Nuclear Proteins | 3 | 0.0 |
*Promoter Regions (Genetics) | 16 | 0.0 |
Proto-Oncogene Proteins c-fos/metabolism | 16 | 15.0 |
Transcription Factor AP-1/metabolism | 23 | 8.0 |
Gene Expression | 5 | 0.0 |
Middle Aged | 8 | 0.0 |
Neoplasm Staging | 2 | 0.0 |
Proto-Oncogene Proteins c-fos/biosynthesis/genetics | 2 | 16.0 |
Transcription Factor AP-1/*biosynthesis | 3 | 50.0 |
Antioxidants/pharmacology | 2 | 1.0 |
Consensus Sequence | 3 | 0.0 |
Mutagenesis | 4 | 0.0 |
Rats, Sprague-Dawley | 5 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 7 | 2.0 |
Transcription Factor AP-1/*genetics/metabolism | 3 | 33.0 |
Phosphorylation/drug effects | 3 | 0.0 |
Enzyme Activation/drug effects/physiology | 2 | 3.0 |
Mutagenesis/physiology | 2 | 2.0 |
Protein Binding/physiology | 2 | 0.0 |
Transcription Factor AP-1/genetics/*metabolism | 7 | 26.0 |
DNA Footprinting | 7 | 2.0 |
Deoxyribonuclease I | 2 | 1.0 |
Nuclear Proteins/metabolism | 10 | 1.0 |
*Regulatory Sequences, Nucleic Acid | 3 | 0.0 |
Response Elements | 3 | 1.0 |
Transcription Factor AP-1 | 2 | 28.0 |
Inflammation/metabolism | 2 | 2.0 |
Kinetics | 4 | 0.0 |
Protein-Serine-Threonine Kinases/pharmacology | 2 | 18.0 |
Signal Transduction/drug effects | 2 | 0.0 |
Up-Regulation/drug effects | 2 | 0.0 |
Calcitriol/*pharmacology | 3 | 1.0 |
Chickens | 2 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Proto-Oncogene Proteins c-fos/genetics/*metabolism | 2 | 8.0 |
Down-Regulation/drug effects | 3 | 1.0 |
Transcription, Genetic/*drug effects | 7 | 2.0 |
DNA, Neoplasm/genetics/metabolism | 2 | 2.0 |
DNA-Binding Proteins/biosynthesis/genetics | 2 | 2.0 |
Protein Biosynthesis | 5 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
Up-Regulation | 8 | 0.0 |
*Enhancer Elements (Genetics) | 3 | 1.0 |
Pregnancy | 4 | 0.0 |
Proto-Oncogene Proteins c-jun/genetics/metabolism | 5 | 14.0 |
Sequence Deletion | 10 | 0.0 |
Cyclosporine/*pharmacology | 2 | 1.0 |
Genes, Reporter/genetics | 2 | 0.0 |
Proto-Oncogene Proteins c-jun/*genetics/metabolism | 4 | 44.0 |
Recombinant Proteins/genetics/metabolism | 2 | 0.0 |
Trans-Activation (Genetics) | 14 | 0.0 |
CHO Cells | 2 | 0.0 |
DNA-Binding Proteins/genetics | 3 | 0.0 |
Hamsters | 3 | 0.0 |
Jurkat Cells | 5 | 0.0 |
Lymphocyte Activation/genetics | 2 | 2.0 |
Promoter Regions (Genetics)/*immunology | 2 | 4.0 |
Transcription Factors/genetics | 4 | 0.0 |
Cell Transformation, Viral | 4 | 1.0 |
Gene Products, tax/genetics/*metabolism | 2 | 15.0 |
Genes, fos/genetics/physiology | 2 | 100.0 |
Genes, jun/genetics/physiology | 2 | 100.0 |
Luciferases/genetics/metabolism | 4 | 1.0 |
T-Lymphocytes/*metabolism | 2 | 0.0 |
*Trans-Activation (Genetics) | 9 | 1.0 |
Flavonoids/pharmacology | 3 | 0.0 |
*Gene Expression Regulation, Enzymologic | 4 | 0.0 |
Imidazoles/pharmacology | 2 | 0.0 |
Pyridines/pharmacology | 2 | 0.0 |
Pyrrolidines/pharmacology | 2 | 4.0 |
Thiocarbamates/pharmacology | 2 | 3.0 |
Gene Products, tax/*metabolism | 3 | 9.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Gene Expression Regulation/drug effects/physiology | 2 | 3.0 |
Tissue Distribution | 2 | 0.0 |
Cattle | 3 | 0.0 |
Chick Embryo | 3 | 0.0 |
Promoter Regions (Genetics)/genetics | 4 | 0.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
Transcription Factor AP-1/genetics/*physiology | 3 | 42.0 |
Neoplasm Proteins/*metabolism | 4 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Binding, Competitive | 8 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 3 | 2.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
Deoxyribonuclease I/metabolism | 2 | 1.0 |
Promoter Regions (Genetics)/*genetics | 6 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 5 | 0.0 |
Response Elements/*genetics | 2 | 3.0 |
Transcription Factors/*genetics | 4 | 0.0 |
Cell Line, Tumor | 5 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Gene Deletion | 5 | 0.0 |
Genes, Dominant | 3 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
*JNK Mitogen-Activated Protein Kinases | 5 | 5.0 |
Male | 14 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Polymerase Chain Reaction | 7 | 0.0 |
Apoptosis/*drug effects | 2 | 0.0 |
Cell Division/drug effects | 7 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 3 | 0.0 |
Nuclear Proteins/analysis | 2 | 1.0 |
*Proto-Oncogene Proteins c-fos | 3 | 42.0 |
Response Elements/genetics | 2 | 1.0 |
Trans-Activation (Genetics)/drug effects | 4 | 1.0 |
Protein p16/biosynthesis | 2 | 10.0 |
Proto-Oncogene Proteins c-jun/*biosynthesis | 4 | 44.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Adult | 5 | 0.0 |
Genes, jun | 8 | 10.0 |
Epithelial Cells/metabolism | 2 | 0.0 |
Liver/metabolism | 2 | 0.0 |
*MAP Kinase Kinase 4 | 2 | 3.0 |
Plasmids/metabolism | 2 | 0.0 |
Dimerization | 3 | 0.0 |
Fibroblast Growth Factor 2/*pharmacology | 2 | 1.0 |
Luciferases/genetics | 2 | 0.0 |
Drug Synergism | 2 | 0.0 |
*CCAAT-Enhancer-Binding Proteins | 3 | 2.0 |
Chloramphenicol O-Acetyltransferase/genetics | 3 | 1.0 |
Naphthalenes/pharmacology | 2 | 2.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
*Mitogen-Activated Protein Kinase Kinases | 3 | 3.0 |
Protein Kinases/metabolism | 3 | 0.0 |
*Signal Transduction | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 9 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
DNA Primers | 11 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Lipopolysaccharides/*pharmacology | 2 | 0.0 |
Macromolecular Substances | 3 | 0.0 |
Substrate Specificity | 3 | 0.0 |
DNA Primers/genetics | 3 | 0.0 |
Genes, jun/*drug effects | 2 | 22.0 |
Promoter Regions (Genetics)/drug effects | 4 | 3.0 |
Protein Kinase C/antagonists & inhibitors/metabolism | 2 | 2.0 |
RNA, Messenger/genetics/metabolism | 4 | 0.0 |
Trans-Activation (Genetics)/*physiology | 4 | 3.0 |
3',5'-Cyclic-Nucleotide Phosphodiesterase/*genetics/metabolism | 2 | 16.0 |
Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 19 | 2 | 0.0 |
Cyclic AMP/*metabolism | 2 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 9 | 0.0 |
rab3A GTP-Binding Protein/genetics | 2 | 100.0 |
DNA-Binding Proteins/*genetics/metabolism | 2 | 0.0 |
Gene Expression Regulation, Viral | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 3 | 0.0 |
CCAAT-Enhancer-Binding Proteins | 2 | 1.0 |
Nuclear Proteins/*metabolism | 3 | 0.0 |
Cyclins/*genetics | 2 | 1.0 |
Recombinant Fusion Proteins | 3 | 0.0 |
Molecular Weight | 2 | 0.0 |
Down-Regulation | 6 | 0.0 |
Trans-Activation (Genetics)/*drug effects | 2 | 2.0 |
*Genes, ras | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism | 3 | 0.0 |
*DNA-(Apurinic or Apyrimidinic Site) Lyase | 2 | 5.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
*DNA-Binding Proteins | 7 | 0.0 |
Gene Expression Regulation/drug effects | 3 | 0.0 |
Interleukin-1/pharmacology | 3 | 0.0 |
Proto-Oncogene Proteins/metabolism | 5 | 0.0 |
*Repressor Proteins | 3 | 0.0 |
Urinary Plasminogen Activator/*genetics | 2 | 11.0 |
Estradiol/*pharmacology | 2 | 0.0 |
Monocytes/drug effects/metabolism | 2 | 2.0 |
Carcinoma, Hepatocellular | 2 | 0.0 |
Fibroblasts/drug effects/metabolism | 2 | 1.0 |
Genetic Vectors | 4 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Tumor Necrosis Factor-alpha/*pharmacology | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/drug effects | 2 | 0.0 |
*Transfection | 2 | 0.0 |
Tumor Necrosis Factor-alpha/pharmacology | 5 | 0.0 |
HIV Long Terminal Repeat/genetics | 2 | 4.0 |
HIV-1/*genetics | 2 | 0.0 |
*Transcription, Genetic | 8 | 0.0 |
Cell Cycle | 2 | 0.0 |
DNA-Binding Proteins/immunology/metabolism | 2 | 10.0 |
Transcription Factors/immunology/metabolism | 2 | 25.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Proto-Oncogene Proteins c-jun/genetics/*metabolism | 9 | 27.0 |
Okadaic Acid/*pharmacology | 3 | 30.0 |
Hydrolysis | 2 | 0.0 |
Proto-Oncogene Proteins c-rel | 2 | 3.0 |
RNA, Messenger/genetics | 6 | 0.0 |
Protein Binding/drug effects | 2 | 0.0 |
Transcription Factor AP-1/*genetics | 4 | 20.0 |
Proto-Oncogene Proteins c-jun/*physiology | 5 | 22.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
*Genes, jun | 8 | 18.0 |
Proto-Oncogene Proteins/*genetics | 3 | 0.0 |
Proto-Oncogene Proteins c-fos/genetics/metabolism | 2 | 7.0 |
Genes, ras | 2 | 0.0 |
Transformation, Genetic | 2 | 1.0 |
DNA | 4 | 0.0 |
Gene Expression Regulation/*drug effects | 3 | 0.0 |
Isoenzymes/genetics | 2 | 0.0 |
Protein Kinase C/genetics | 2 | 16.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/physiology | 2 | 5.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/*metabolism | 2 | 2.0 |
Proto-Oncogenes/genetics | 2 | 6.0 |
RNA, Messenger/biosynthesis | 5 | 0.0 |
Cyclosporine/pharmacology | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Recombinant Fusion Proteins/biosynthesis | 4 | 0.0 |
Transcription, Genetic/drug effects | 3 | 0.0 |
*Transcription Factors | 3 | 0.0 |
Calcium/physiology | 2 | 0.0 |
Genes, fos/*genetics | 2 | 10.0 |
Genes, jun/*genetics | 2 | 28.0 |
DNA-Binding Proteins/genetics/metabolism | 3 | 0.0 |
Transcription Factors/genetics/metabolism | 3 | 0.0 |
Interleukin-6/pharmacology | 2 | 0.0 |
Transcription Factor, Sp1/metabolism | 2 | 0.0 |
Chimeric Proteins/biosynthesis | 2 | 4.0 |
*Genes, fos | 3 | 4.0 |
Multigene Family | 3 | 0.0 |
Keratinocytes/*metabolism | 2 | 2.0 |
Human T-lymphotropic virus 1/*genetics | 2 | 3.0 |
Choriocarcinoma | 2 | 5.0 |
Proto-Oncogene Proteins c-fos/biosynthesis | 2 | 6.0 |
Rabbits | 2 | 0.0 |
Dexamethasone/*pharmacology | 2 | 0.0 |
Protein Kinases/*metabolism | 3 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Biopolymers | 2 | 1.0 |
Dactinomycin/pharmacology | 2 | 0.0 |
NF-kappa B/*physiology | 2 | 2.0 |
Proto-Oncogene Proteins c-jun/*genetics/*metabolism | 2 | 100.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
In Vitro | 5 | 0.0 |
Genes, fos | 5 | 4.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Melanoma/*metabolism | 2 | 3.0 |
Protein Precursors/*biosynthesis/genetics | 2 | 20.0 |
Chloramphenicol O-Acetyltransferase/metabolism | 2 | 1.0 |
Leucine Zippers | 3 | 1.0 |
Oligodeoxyribonucleotides | 3 | 0.0 |
*Oncogenes | 2 | 0.0 |
*Gene Expression | 2 | 0.0 |
Plasmids | 4 | 0.0 |
*Genes, Immediate-Early | 2 | 6.0 |
*Lymphocyte Activation | 3 | 0.0 |
Protein Processing, Post-Translational | 2 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Oligodeoxyribonucleotides/chemistry | 3 | 1.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
DNA-Binding Proteins/*chemistry | 2 | 2.0 |
Cyclic AMP/metabolism | 2 | 0.0 |
Genes, Tumor Suppressor | 3 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Neoplasm Proteins/*pharmacology | 2 | 15.0 |
